StockData
Xenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc. (XBIO) stock

XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.53−0.08 (-4.97%)

Close on Nov 18, 2026Market cap $3.59MP/E –Yield –

Xenetic Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Xenetic Biosciences's revenue for the twelve months ending Jun 30, 2026 was $3.26M, up 33.3% year over year. For fiscal 2025 it was $2.98M, up 19.0% from the year before. The highest annual figure on record is $7.59M in fiscal 2017.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.98M+19.0%
FY2024Dec 31, 2024$2.50M-1.6%
FY2023Dec 31, 2023$2.54M+48.8%
FY2022Dec 31, 2022$1.71M+47.1%
FY2021Dec 31, 2021$1.16M+165.6%
FY2020Dec 31, 2020$436.94K+2460.3%
FY2019Dec 31, 2019$17.07K–
FY2018Dec 31, 2018$0-100.0%
FY2017Dec 31, 2017$7.59M+152.8%
FY2016Dec 31, 2016$3.00M–
FY2015Dec 31, 2015$0–
FY2014Dec 31, 2014$0-100.0%
FY2013Dec 31, 2013$1.00M+240.6%
FY2012Dec 31, 2012$293.60K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$660.60K+12.0%
Q1 FY2026Mar 31, 2026$806.92K+36.0%
Q4 FY2025Dec 31, 2025$766.30K+18.1%
Q3 FY2025Sep 30, 2025$1.03M+67.2%
Q2 FY2025Jun 30, 2025$589.90K-18.8%
Q1 FY2025Mar 31, 2025$593.26K+16.1%
Q4 FY2024Dec 31, 2024$648.82K-3.4%
Q3 FY2024Sep 30, 2024$614.24K+0.5%
Q2 FY2024Jun 30, 2024$726.40K+11.6%
Q1 FY2024Mar 31, 2024$510.82K-15.7%
Q4 FY2023Dec 31, 2023$671.96K+61.3%
Q3 FY2023Sep 30, 2023$611.17K+57.1%
Q2 FY2023Jun 30, 2023$651.01K+95.7%
Q1 FY2023Mar 31, 2023$605.84K+73.5%
Q2 FY2022Jun 30, 2022$416.71K+44.9%
Q1 FY2022Mar 31, 2022$388.99K+103.4%
Q4 FY2021Dec 31, 2021$332.60K+119.8%
Q3 FY2021Sep 30, 2021$349.27K+201.3%
Q2 FY2021Jun 30, 2021$287.60K+154.7%
Q1 FY2021Mar 31, 2021$191.22K+237.0%
Q4 FY2020Dec 31, 2020$151.33K+786.7%
Q3 FY2020Sep 30, 2020$115.93K–
Q2 FY2020Jun 30, 2020$112.93K–
Q1 FY2020Mar 31, 2020$56.75K–
Q4 FY2019Dec 31, 2019$17.07K–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0-100.0%
Q1 FY2019Mar 31, 2019$0-100.0%
Q4 FY2018Dec 31, 2018$0-100.0%
Q3 FY2018Sep 30, 2018$0–
Q4 FY2017Dec 31, 2017$7.50M–
Q3 FY2017Sep 30, 2017$85.00K–
Q4 FY2016Dec 31, 2016$3.00M–
Q3 FY2016Sep 30, 2016$0–

More Xenetic Biosciences figures

See a number that looks wrong?